Quantcast

Latest Bone marrow Stories

2011-07-07 05:45:00

MELBOURNE, Australia, July 7, 2011 /PRNewswire/ -- Key points: Mesoblast's first Phase 3 trial submission cleared by United States Food and Drug Administration (FDA) Rapid clearance (within 30 days) further validation of Mesoblast's clinical, regulatory, and manufacturing capabilities Mesoblast's proprietary adult stem cells expand hematopoietic precursor cells in umbilical cord blood 40-fold, enabling rapid bone marrow reconstitution with lowered risk of life-threatening Graft Versus...

2011-06-13 11:09:00

'Novel' Reality Program Aims to Boost Breast Cancer, Leukemia Awareness...and Recruit New Bone Marrow Donors NEW YORK, June 13, 2011 /PRNewswire-USNewswire/ -- A legal thriller which tells the true story of a woman who battled breast cancer, then leukemia, and finally got a successful bone marrow transplant is being used to educate the public about the constant need for bone marrow donors. "The Matriarchs," a novel now available in Amazon® print and...

2011-06-13 00:00:28

The organization takes on Alice's wish in the U.S. by registering donors for free at GetSwabbed.org New York, NY (PRWEB) June 12, 2011 Alice Pyne, a terminally-ill British teenager became an online sensation after posting a wish list of things she would like to do before she dies on her personal blog. The teen, who has been battling Hodgkins Lymphoma for the last four years, recently found out that the cancer is spreading throughout her entire body. "I know that the cancer is gaining on me...

2011-06-07 08:30:00

CLEVELAND, June 7, 2011 /PRNewswire-USNewswire/ -- Arteriocyte(TM), a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops proprietary stem cell and tissue engineering based therapies, announced today that they have entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Institute of Surgical Research (USAISR) at Fort Sam Houston, Texas. The 3-year CRADA, entitled "The Use of...

2011-06-02 08:00:00

RANCHO CORDOVA, Calif., June 2, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it has received FDA clearance of its 510(k) submission for the use of its Res-Q(TM) 60 (Res-Q) System technology to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of blood at the patient's point-of-care. The PRP is mixed with autograft...

2011-05-16 07:04:06

(Ivanhoe Newswire) -- New-fangled research examines the therapeutic use of human stem cells from bone marrow against acute lung injury and identifies TNF-a-induced protein 6 as a foremost molecular component of stem cell action. Acute lung injury is a chief complication of critically ill patients resulting in pulmonary edema, hypoxia and, in the worst cases, organ failure.  Accordingly, up to 40 percent of all sufferers die for the reason that their bodies' immune systems overreact in an...

2011-05-13 10:37:42

New research, published in BioMed Central's open access journal Stem Cell Research & Therapy, investigates the therapeutic use of human stem cells from bone marrow against acute lung injury and identifies TNF-ÃŽ±-induced protein 6 as a major molecular component of stem cell action. Acute lung injury is a major complication of critically ill patients resulting in pulmonary edema, hypoxia and, in the worst cases, organ failure. Consequently up to 40% of all sufferers die...

2011-05-12 11:09:50

NYU Cancer Institute researchers identify novel mutations in a cell communication pathway A new study by the NYU Cancer Institute, an NCI-designated cancer center, sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults. The researchers discovered that novel mutations in an intracellular communication pathway called Notch led to the cancer, pointing to a potential new target for treating this disease. Notch has already been implicated in another...

2011-05-11 01:00:00

SOMERSET, N.J., May 11, 2011 /PRNewswire/ -- Terumo Americas Holding, Inc., a U.S. subsidiary of Japan's Terumo Corporation, one of the world's leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world's first point-of-care technology...

2011-05-09 21:14:56

Surgeon and Professor Michael Olausson was able to create a new connection with the aid of this blood vessel between the liver and the intestines, necessary to cure the girl. The girl is now in good health, and her prognosis is very good. The girl developed during her first year of life a blood clot in the blood vessel that leads blood from the intestines to the liver. This introduced the risk that she would experience life-threatening internal bleeding. The condition can be cured if it is...


Latest Bone marrow Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'